Market Shadows Added to Two Beaten Up Stocks Today

Sometimes the best new idea is to increase your position in old ideas.

We added 38 new shares of Quest Diagnostics (DGX) @ $53.36 and 80 extra shares of Bio Reference Labs (BRLI) @ $25.42 to our Virtual Value Portfolio this afternoon.

Both stocks appear to be suffering from year-end tax-related sell-offs today. We’ll get a quick rebate on DGX as it goes ex-dividend for 30-cents a share this Friday.

The combined purchases were paid for from our cash reserve fund.

Our portfolio looks to be finishing out 2013 at a new all-time record.  See details of all our closed-out and open holdings by clicking here.